Project description
A 3D biomimetic model of the tumour microenvironment
The microenvironment plays a defining role in tumourigenesis, tumour progression, metastasis formation and resistance to therapeutics. Monolayer cultures of tumour cells fail to recapitulate the essentials of the microenvironment of native tumours, while mouse models suffer from limited relevance, low efficiency and high cost. A 3D human in vitro tumour model that faithfully mimics the native microenvironment is critical for the understanding of molecular mechanisms and signalling pathways that govern complex pathological processes. The EU-funded MiTuMi project aims to introduce a biomimetic human lung tumour model that allows independent tuning and control of biochemical and mechanical components of the microenvironment, thus facilitating the study of cellular events that govern tumourigenesis, metastasis, drug resistance and tumour heterogeneity.
Objective
Lung cancer is the leading cause of cancer-related mortality in the world. It most often gets diagnosed at an advanced stage with a 5-year survival rate as low as 5%. Despite recent advances in development of therapeutics, lack of a comprehensive understanding of the complexity and dynamicity of the tumor microenvironment hinders effective clinical outcome. Tumor microenvironment plays a crucial role in tumorigenesis and subsequent disease progression leading to metastasis as well as resistance to therapeutics. Conventional monolayer culturing of tumor cells fails to recapitulate the essential microenvironmental aspects of native tumors whereas mouse models suffer from limited relevance, high cost and low throughput. A three-dimensional (3D) human in vitro tumor model that faithfully mimics the tumor microenvironment is key to advance the current understanding of biological processes and signaling pathways that govern these complex pathological events. I propose a biomimetic human lung tumor model that allows independent tunability and control of aberrant biochemical and mechanical aspects of the tumor microenvironment to study cellular events that govern tumorigenesis (Objective1), metastasis and drug resistance (Objective2) and patient heterogeneity (Objective3). Following a highly interdisciplinary approach where tissue engineering, material science, medicine and molecular biology converges, the implications of a tunable and biomimetic 3D human tumor model is substantial for the future of precision-medicine and development of patient- specific therapeutic regimens.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- social sciences sociology demography mortality
- medical and health sciences clinical medicine oncology lung cancer
- medical and health sciences medical biotechnology tissue engineering
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
34450 Istanbul
Türkiye
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.